'Brain pacemakers' show some promise in Parkinson's study

Aid movement more than drugs, but have risks

CHICAGO - Parkinson's sufferers who had electrodes implanted in their brains improved substantially more than those who took only medicine, according to the biggest test yet of deep brain stimulation.

The study, which followed patients for six months, offers the most hopeful news to date for Parkinson's sufferers. The new technique reduced tremors, rigidity, and flailing of the limbs and allowed people to move freely for nearly five extra hours a day.

But the research also revealed higher-than-expected risks. About 40 percent of the patients who received these "brain pacemakers" suffered serious side effects, including a surprising number of falls with injuries.

"We had one patient who felt so good he went up to repair his roof, fell down, and broke both his legs," said lead author Fran Weaver of Hines Veterans Affairs Hospital, outside Chicago. "Patients are feeling so much better, they forget they still have Parkinson's."

There is no cure for Parkinson's disease, which affects more than 1 million Americans. Patients suffer from increasingly severe tremors and periodically rigid limbs as their brains stop making dopamine, a chemical needed for movement. They can have trouble walking, speaking, and writing, and often struggle with depression.

Standard treatments include drugs to stimulate dopamine. But over time, the medicines can produce flailing movements that are as troubling as Parkinson's tremors.

With deep brain stimulation, which was approved by the Food and Drug Administration in 2002 for advanced Parkinson's and which had been performed on thousands of patients, a surgeon implants electrodes in the brain, which are then connected to a pacemaker-like device that can be adjusted and turned off and on. That device, implanted under the collarbone or in the abdomen, sends tiny electrical pulses to the brain, disabling overactive nerve cells.

The latest findings were published in today's Journal of the American Medical Association. The researchers studied 255 people with advanced Parkinson's at seven VA and six university hospitals. Patients were randomly assigned to have surgery plus the standard medication, or medication alone.

After six months, patients visited neurologists who did not know whether they had had surgery or medication. In the surgery group, 86 out of 121 (71 percent) saw meaningful improvement in movement, as scored by the neurologists. In the medication group, 43 out of 134 patients (32 percent) showed meaningful improvement.

In the surgery group, 49 had serious problems, including infections, falls, and one death because of complications from the surgery. In the control group, only 15 people encountered serious problems.